Radiomics analysis based on multiparametric magnetic resonance imaging for differentiating early stage of cervical cancer
Open Access
- 2 February 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1336640
Abstract
Objective: To investigate the performance of multiparametric magnetic resonance imaging (MRI)—based radiomics models in differentiating early stage of cervical cancer (Stage I-IIa vs. IIb-IV).Methods: One hundred patients with cervical cancer who underwent preoperative MRI between June 2020 and March 2022 were retrospectively enrolled. Training (n = 70) and testing cohorts (n = 30) were assigned by stratified random sampling. The clinical and pathological features, including age, histological subtypes, tumor grades, and node status, were compared between the two cohorts by t-test or chi-square test. Radiomics features were extracted from each volume of interest (VOI) on T2-weighted images (T2WI) and apparent diffusion coefficient (ADC) maps. The data balance of the training cohort was resampled by synthesizing minority oversampling techniques. Subsequently, the adiomics signatures were constructed by the least absolute shrinkage and selection operator algorithm and minimum-redundancy maximum-relevance with 10-fold cross-validation. Logistic regression was applied to predict the cervical cancer stages (low [I-IIa]) and (high [IIb–IV] FIGO stages). The receiver operating characteristic curve (area under the curve [AUC]) and decision curve analysis were used to assess the performance of the radiomics model.Results: The characteristics of age, histological subtypes, tumor grades, and node status were not significantly different between the low [I-IIa] and high [IIb–IV] FIGO stages (p > 0.05 for both the training and test cohorts). Three models based on T2WI, ADC maps, and the combined were developed based on six radiomics features from T2WI and three radiomics features from ADC maps, with AUCs of 0.855 (95% confidence interval [CI], 0.777–0.934) and 0.823 (95% CI, 0.727–0.919), 0.861 (95% CI, 0.785–0.936) and 0.81 (95% CI, 0.701–0.918), 0.934 (95% CI, 0.884–0.984) and 0.902 (95% CI, 0.832–0.972) in the training and test cohorts.Conclusion: The radiomics models combined T2W and ADC maps had good predictive performance in differentiating the early stage from locally advanced cervical cancer.Keywords
This publication has 37 references indexed in Scilit:
- A Network Meta-Analysis on the Diagnostic Value of Different Imaging Methods for Lymph Node Metastases in Patients With Cervical CancerTechnology in Cancer Research & Treatment, 2018
- Role of Functional Magnetic Resonance Imaging Derived Parameters as Imaging Biomarkers and Correlation with Clinicopathological Features in Carcinoma of Uterine CervixJournal of Clinical and Diagnostic Research, 2017
- Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countriesThe Lancet, 2017
- Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapyJournal of Magnetic Resonance Imaging, 2016
- Radiomics: Images Are More than Pictures, They Are DataRadiology, 2016
- Cancer statistics in China, 2015CA: A Cancer Journal for Clinicians, 2016
- Comparison of MRI and high‐resolution transvaginal sonography for the local staging of cervical cancerJournal of Clinical Ultrasound, 2015
- Identifying a low-risk group for parametrial involvement in microscopic Stage IB1 cervical cancer using criteria from ongoing studies and a new MRI criterionBMC Cancer, 2015
- Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 yearsBritish Journal of Cancer, 2013
- The value of apparent diffusion coefficient in the assessment of cervical cancerEuropean Radiology, 2012